Venlafaxine HCl SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Venlafaxine Hydrochloride as the active ingredient. These pellets are developed for incorporation into oral dosage formulations requiring a sustained-release profile.
Swapnroop Drugs & Pharmaceuticals offers Venlafaxine HCl SR Pellets in 22.5% and 39% strengths, providing formulation flexibility for capsule filling and multiparticulate dosage-form development.
Venlafaxine Hydrochloride has the molecular formula C₁₇H₂₇NO₂·HCl, molecular weight 313.86 g/mol, and CAS Number 99300-78-4.
Venlafaxine HCl SR Pellets are available in:
These strengths are listed in SDP's published pellet product portfolio.
Venlafaxine HCl SR Pellets can be used for:
Venlafaxine Hydrochloride is the hydrochloride salt form of Venlafaxine. The finished pellet system combines the active ingredient with suitable pellet-formulation and release-controlling components to achieve the intended sustained-release profile.
The final release characteristics can depend on active loading, pellet composition, coating system, coating level and manufacturing parameters. Therefore, finished-pellet specifications should be evaluated against the applicable product specification rather than directly applying API specifications.
Venlafaxine HCl SR Pellets can be supplied according to the required strength, quantity, packaging requirements and product specifications. Packaging is selected to maintain product quality during storage and transportation.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 95.0% – 105.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.1% |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 0.5% |